
Horse therapy program brings joy to kids with learning disabilities in Namibia
De Meyer runs a program in the southern African country of Namibia that harnesses the power but also the gentleness of horses to help children with learning disabilities and conditions like ADHD and autism.
Each weekday morning, de Meyer's dusty paddock just outside the capital, Windhoek, is enlivened by a group of eight to 10 children from one of the special schools she helps. The children ride the horses, groom them, stroke them and often, de Meyer says, talk to them.
Merci who participates in the 'Enabling Through the Horse', therapy program, petting one of the animals horse.
De Meyer grew up on a farm surrounded by horses and they've always been part of her life. She said they have a quality that is invaluable: They don't judge the children, no matter how different they are.
'The horse is the hero in this whole situation because these kids don't want to be around a lot of people,' de Meyer said.
De Meyer's program, 'Enabling Through the Horse', is supported by the Namibian Equestrian Federation and won an award last year from the International Equestrian Federation because it 'underlines the wonderful characteristics of the horse in exuding sensitivity and intuition'.
Horse therapy has been promoted by autism groups and those that work with children with learning disabilities as having a positive impact. And animal therapy in general has been found to be useful in many instances, like dogs that help military veterans with post-traumatic stress disorder and therapy cats that are taken to hospitals and nursing homes.
Program founder De Meyer (in red) grew up on a farm surrounded by horses.
Some survivors of the devastating 2023 Hawaii wildfires in the United States found relief in horse therapy while grieving loved ones they had lost.
De Meyer jokes she has 'two-and-a-half horses'. These include two Arabians – a white mare named Faranah and a brown gelding, Lansha – while the 'half' is a miniature horse called Bonzi, who is about head-high for a five-year-old.
The Arabians are often the most useful for the children's therapy because of their size, de Meyer said.
'It gives them self-esteem. When they stroke the horse, the therapy starts because this is a very big animal compared to their height, and they are not scared to stroke the horse ... and then to ride it and tell the horse what they want,' she said.
De Meyer works with children with a range of conditions or disabilities, including autism, attention-deficit/hyperactivity disorder, Down syndrome, those who are non-verbal or touch sensitive, and some who were born with fetal alcohol syndrome and have developmental problems.
She has received interest from other countries in Africa and Asia to start similar programs there.
'The changes that I've seen with the learners are significant,' said Chriszell Louw, a teacher at Dagbreek School, which says it is one of just two government schools in Namibia for children with intellectual disabilities.
'We have a learner that likes to talk a lot. When we come here, she knows she has to keep quiet. She sits in her place.'
'Some of them you see they are more open, they are happy. Some of them were very scared when they started with the horse riding but now they are very excited. When they hear we're going to the horses they are very excited and just want to go by themselves,' Louw said.
De Meyer said her program helps with fine-motor skills, gross-motor skills, muscle strengthening, coordination, balance and posture, all important for kids who struggle to sit at a desk at school and learn.
One simple exercise de Meyer has children do when they ride is to let go of the reins and stretch their arms out straight and to the sides, using only their torso and lower body to balance as a groom leads the horse around the paddock.
Some of the kids break out in smiles when they let go and look like they're soaring.
'We make the world different for these kids,' de Meyer said. – AP
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Star
a day ago
- The Star
Stay alert for chikungunya fever threat, leading expert tells Hongkongers
Hongkongers should remain vigilant against chikungunya fever, leading expert Yuen Kwok-yung has said, stressing that the mosquito-borne disease could cause prolonged and severe joint pain due to weak immunity levels among the population. Yuen, chair of infectious diseases at the University of Hong Kong's department of microbiology, issued the warning on Thursday following recent outbreaks in mainland China, including 3,000 cases reported in Guangdong province's Foshan city. While the last chikungunya fever cases registered in Hong Kong were in 2019, Yuen said that any potential outbreak in the city could be on a large scale. 'Any outbreak could be major because we have no immunity, so we should not take it lightly,' he told a radio programme. 'Normally, you might only experience a fever, rash and swollen joints. Most people will be fine, but you must not forget that if you have a chronic illness, it can be very serious to those who are very old or very young. 'It can affect your brain and cause inflammation of the retina or even retinal detachment. It can also impact the heart.' Yuen pointed to the recent surge in cases in Foshan, where the number of infections had increased from 478 on July 15 to more than 2,500 just seven days later. Mainland authorities reported on Wednesday that the caseload in Foshan had jumped to 3,000, with most of them being logged in the Shunde district. The World Health Organization on Tuesday also issued an urgent call for action against chikungunya fever as the virus had been affecting other parts of the world, including Réunion Island, Madagascar, Kenya and India. Europe has also seen a growing number of imported cases and some local transmission. Chikungunya fever is spread by Aedes albopictus mosquito bites, with cases typically developing fever and joint pain that can last for a long period. Other potential symptoms include muscle pain, nausea and rashes. 'After being infected, some people mistakenly believe they'll feel better in a few days, but that's not the case. The joint inflammation and swelling can persist for more than three months in about 40 per cent of patients,' Yuen said. 'For some, these symptoms can even last for years, leading to premature joint degeneration. The name 'chikungunya' itself comes from an African language and means 'to become contorted', which describes how the intense joint pain can cause people to hunch over. This is why everyone should take the disease seriously.' He urged residents returning from affected areas to seek medical attention immediately if they developed a fever, to be tested for the chikungunya virus, and to apply mosquito repellents with Deet. Infectious disease specialist Dr Joseph Tsang Kay-yan also warned that the joint pain from chikungunya fever was not limited to the period of illness. 'Even after the fever subsides, this pain can persist for weeks, months or even years, which can be considered a long-term after-effect,' he told a separate radio show. 'Sometimes, there's a chance that long-term use of painkillers will be needed to reduce inflammation and pain.' Tsang warned that the risk was indeed higher for the elderly and stressed that complacency was not an option when it came to older people, newborns and those with chronic illnesses, as they were considered special groups who could face complications. Hong Kong last recorded cases of chikungunya fever in 2019, with the tally reaching 11 patients. The city also reported two cases in 2018, one in 2017 and eight in 2016. All cases between 2016 and 2019 were imported. Lee Ming-wai, pest control officer in-charge at the Food and Environmental Hygiene Department, said authorities were monitoring the Aedes albopictus index through gravid traps. He added that the index during June's peak mosquito season was similar to that of the previous few years. 'The department will continue to monitor the situation at boundary control points using these traps, and will intensify mosquito extermination efforts if Aedes albopictus mosquitoes are detected,' Lee said. 'The department will promote a citywide mosquito eradication campaign to clear stagnant water and reduce mosquito infestation.' - SOUTH CHINA MORNING POST


The Star
3 days ago
- The Star
Africa CDC warns of widespread drug resistance across Africa
ADDIS ABABA, July 24 (Xinhua) -- The Africa Centers for Disease Control and Prevention (Africa CDC) has warned of widespread drug resistance on the continent, threatening to reverse decades of health and development gains. The Africa CDC, in its latest study titled "Mapping Antimicrobial Resistance and Antimicrobial Use Partnership," released Wednesday, said the "alarming rate" of antimicrobial resistance across 14 African countries poses an urgent continental public health threat. The study, the largest of its kind conducted in Africa, analyzed more than 187,000 test results from 205 laboratories between 2016 and 2019 in 14 countries, including Ethiopia, Ghana, Kenya, Malawi, Mali, and Nigeria, revealing a growing ineffectiveness of antibiotics against common bacterial infections. Drug resistance occurs when bacteria change in ways that make antibiotics used to treat infections less effective. The phenomenon results in common infections becoming harder to treat, more expensive to manage, and more likely to spread, according to the study. It highlighted drug resistance as a growing epidemic affecting multiple countries across the continent. One of the "most concerning" findings is that resistance to a powerful group of antibiotics, known as third-generation cephalosporins, is exceptionally high in Ghana and Malawi. The study also revealed demographic disparities in drug-resistant infections, with older adults and hospitalized patients being particularly vulnerable. It said the existing demographic disparities underscore the need for targeted interventions to protect at-risk populations. The Africa CDC also highlighted "serious gaps" in laboratory infrastructure and data collection systems. Findings reveal that fewer than 2 percent of health facilities were equipped to test for bacterial infections, and only 12 percent of drug resistance records were linked to patient information.


The Star
4 days ago
- The Star
First malaria drug for infants receives Swiss approval
A mother and her child sitting on a bed covered with a mosquito net to protect against malaria-carrying mosquitoes near the town of Bagamoyo in Tanzania. The African nation is one of eight that is expediting approval of the first malaria drug for infants weighing less than 4.5kg. — AFP filepic The first malaria treatment for newborns and young infants has received approval from Swiss health regulators, with eight African countries poised to roll the drug out rapidly, Swiss pharmaceutical giant Novartis announced on July 8 (2025). Malaria is a major killer in Africa, with the continent accounting for 95% of the 597,000 deaths from the disease worldwide in 2023, according to the World Health Organization (WHO). Of those deaths, about 76% – more than 432,000 – were children under five years old, according to the WHO. The infant version of the combined drugs artemether and lumefantrine was developed by Novartis in collaboration with the Medicines for Malaria Venture (MMV), a Geneva-based organisation specialising in research and development of medicines against the disease. 'Until now, there has been no approved malaria treatment for infants weighing less than 4.5kg,' Novartis said in a statement. The approval from Switzerland's health authority is for a dose designed for babies weighing two to five kilogrammes. Eight of the countries hit hardest by malaria – Burkina Faso, Ivory Coast, Kenya, Malawi, Mozambique, Nigeria, Tanzania and Uganda – participated in the Swiss approval process. The countries are now expected to approve the treatment quickly themselves, under a programme to facilitate access to medicines for low- and middle-income countries, Novartis said. The pharmaceutical company said it would introduce the treatment 'on a largely not-for-profit basis' to increase access in places where the mosquito-borne disease is endemic. An estimated 263 million people worldwide had malaria in 2023, according to the WHO. Funding to fight the disease is under threat after US President Donald Trump's moves to cut foreign aid. The US government previously provided around 40% of annual funding globally for control and research into malaria. – AFP